Business Context and Reporting Period
This Form 8-K reports on the 2022 Annual Meeting of Stockholders held by NanoViricides, Inc. on December 17, 2022. The company is incorporated in Nevada and trades on the NYSE American under the symbol NNVC. The filing details the voting outcomes of four proposals and the subsequent adjournment of the meeting regarding one specific proposal.
Key Financial Metrics
This filing is a current report regarding corporate governance events and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes and Voting Results
Stockholders representing 57% of the voting capital stock participated in the meeting. The results for the proposals were as follows:
- Proposal 1 (Redomicile): The proposal to redomicile the company from Nevada to Delaware failed to obtain sufficient votes.
- Proposal 2 (Director Elections): Stockholders re-elected Theodore Rokita (Class I), Makarand Jawadekar (Class II), and Brian Zucker (Class II) for two-year terms.
- Proposal 3 (Executive Compensation): Stockholders approved an award of 10,204 Series A Preferred Shares to President Anil Diwan.
- Proposal 4 (Auditor Ratification): Stockholders ratified the appointment of EisnerAmper, LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2023.
Outlook, Management Commentary, and Contingencies
Due to the failure of Proposal 1, the Annual Meeting was adjourned to February 7, 2023, at 10:00 a.m. Eastern Time. The purpose of the adjournment is to allow additional time for stockholders to vote on the redomicile proposal. The adjourned meeting will be held at the company's offices in Shelton, Connecticut. No other guidance or risk factors were disclosed in this specific filing.
Key Facts for Investor Verification
- Verify the outcome of the adjourned meeting scheduled for February 7, 2023, regarding the redomicile to Delaware.
- Confirm the impact of the 10,204 Series A Preferred Shares granted to the President on future dilution.
- Review the full Proxy Statement filed on November 15, 2022, for detailed rationale behind the redomicile proposal.
- Note that the company remains a Nevada corporation pending the outcome of the adjourned vote.